Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Apr;102(4):327-35.
doi: 10.5935/abc.20140040.

Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis

[Article in English, Portuguese]
Affiliations
Multicenter Study

Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis

[Article in English, Portuguese]
André Luiz Cerqueira de Almeida et al. Arq Bras Cardiol. 2014 Apr.

Abstract

Background: Subclinical cardiovascular disease is prevalent in patients with Metabolic Syndrome (MetSyn). Left ventricular (LV) circumferential strain (εCC) and longitudinal strain (εLL), assessed by Speckle Tracking Echocardiography (STE), are indices of systolic function: shortening is indicated by negative strain, and thus, the more negative the strain, the better the LV systolic function. They have been used to demonstrate subclinical ventricular dysfunction in several clinical disorders.

Objective: We hypothesized that MetSyn is associated with impaired myocardial function, as assessed by STE.

Methods: We analyzed Multi-Ethnic Study of Atherosclerosis (MESA) participants who underwent STE and were evaluated for all MetSyn components.

Results: Among the 133 participants included [women: 63%; age: 65 ± 9 years (mean ± SD)], the prevalence of MetSyn was 31% (41/133). Individuals with MetSyn had lower εCC and lower εLL than those without MetSyn (-16.3% ± 3.5% vs. -18.4% ± 3.7%, p < 0.01; and -12.1% ± 2.5% vs. -13.9% ± 2.3%, p < 0.01, respectively). The LV ejection fraction (LVEF) was similar in both groups (p = 0.09). In multivariate analysis, MetSyn was associated with less circumferential myocardial shortening as indicated by less negative εCC (B = 2.1%, 95%CI:0.6 3.5, p < 0.01) even after adjusting for age, ethnicity, LV mass, and LVEF). Likewise, presence of MetSyn (B = 1.3%, 95%CI:0.3 2.2, p < 0.01) and LV mass (B = 0.02%, 95% CI: 0.01-0.03, p = 0.02) were significantly associated with less longitudinal myocardial shortening as indicated by less negative εLL after adjustment for ethnicity, LVEF, and creatinine.

Conclusion: Left ventricular εCC and εLL, markers of subclinical cardiovascular disease, are impaired in asymptomatic individuals with MetSyn and no history of myocardial infarction, heart failure, and/or LVEF < 50%.

PubMed Disclaimer

Conflict of interest statement

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Representative LV εCC curve from a participant without MetSyn. Different colors depict different myocardial segments. The white strain curve represents the global circumferential peak strain. ES: end-systole; εCC: circumferential strain; LV: left ventricle.
Figure 2
Figure 2
Representative LV εLL curve from a participant with MetSyn. Different colors depict different myocardial segments. The white strain curve represents the global longitudinal peak strain. ES: end-systole; εLL: longitudinal strain; LV: left ventricle; LA: Left atrium; RV: Right ventricle; RA: Right atrium; MV: Mitral valve

Similar articles

Cited by

References

    1. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92(2):399–404. - PubMed
    1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132. - PubMed
    1. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol. 2005;46(3):457–463. - PubMed
    1. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care. 2003;26(4):1251–1257. - PubMed
    1. Hassinen M, Komulainen P, Lakka TA, Vaisanen SB, Haapala I, Gylling H, et al. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med. 2006;166(4):444–449. - PubMed

Publication types

MeSH terms